News

The following statement—from Global Health Council, supported by the Global Health Technologies Coalition—was delivered at the 72nd World Health Assembly on agenda item 12.1: Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefit.Global Health Council supported by Global Health Technologies Coalition encourages innovative technologies and approaches to accelerate universal influenza vaccine research and development. Pandemic influenza is a looming public health threat — as the World Health Organization has noted, its emergence is a “matter of when not if — with far-reaching consequences.”  The only way that we can take the threat of influenza off the table is with a vaccine that protects against influenza viruses we know and those we have yet to experience. Combating this significant threat to global health and shortening the timeline for a vaccine will require significant prioritization, collaboration, and investment in new approaches by WHO, member states as well as new partners.The world needs a universal influenza vaccine to prevent massive loss of life and the extraordinary economic impact that a pandemic would have on our society. Progress has been slow but given the urgency, we need to explore new ways to solve this problem.

The following statement—from Global Health Council supported by Global Health Technologies Coalition, Global Water 2020, and Infectious Diseases Society of America—was delivered at the 72nd World Health Assembly on agenda item 11.8: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues, Antimicrobial Resistance.Global Health Council supported by the Global Health Technologies Coalition, Global Water 2020 and the Infectious Diseases Society of America are pleased to see attention focused on antimicrobial resistance. AMR threatens to roll back medical progress by further complicating treatment of tuberculosis, pneumonia, malaria, typhoid, diarrheal diseases, and hospital-associated infections. Cancer chemotherapy, transplantation and other complex surgeries all rely upon the availability of antibiotics. We applaud recognition of the need for new antimicrobials, diagnostics and vaccines as well as stewardship, surveillance, infection prevention and control, and access to safe water, sanitation, and hygiene in healthcare facilities to effectively combat AMR. We hope that WHO and member states continue progress toward the commitments made at the UN High Level Meeting on AMR.Innovation and R&D must be at the heart of any agenda to tackle AMR. In April 2019 one of the few companies in the antibiotic market—Achaogen—entered bankruptcy, despite having launched an important new antibiotic last year. This news sent a devastating signal to investors, who were already shying away from antibiotic development. New incentives are needed to protect the antibiotic pipeline.  We appreciate the increasing number of countries providing data to the GLASS surveillance system, though we recognize the need to expand this effort to include additional countries and more robust data. We appreciate the support WHO and member states are providing for the implementation of stewardship and infection prevention programs, but recognize that significantly more resources are needed for widespread meaningful uptake. Further investment in resources needed to prevent infections, and thus prevent the need for antibiotic use, is essential.  National action plans are a useful tool to drive all of this progress.We thank WHO for continued efforts and encourage member states prioritize AMR investments.

The following statement—from Global Health Council (GHC), supported by Global Health Technologies Coalition (GHTC), PAI, Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), Management Sciences for Health (MSH), Living Goods, Partners In Health (PIH), and RTI International—was delivered at the 72nd World Health on agenda item 11.5: Universal health coverage.GHC supported by GHTC, PAI, EGPAF, MSH, Living Goods, PIH and RTI International thank you for the opportunity to comment on the agenda item on UHC in preparation for the HLM.The SDGs call for achieving UHC, as well as for reducing maternal mortality; ending preventable deaths of newborns and children; and ending the epidemics of AIDS, TB, malaria and neglected tropical diseases. To ensure coherence among these goals, special efforts must be made to reach the most vulnerable populations. In addition, it is essential to have innovation and R&D elevated as a central pillar to achieving UHC.The Political Declaration should include language to strengthen health systems down to the community level by investing in R&D, health workers, and capacity building programs to ensure access to quality care for all. We urge the inclusion of measures to disaggregate data by age and gender in order to ensure all people are counted when measuring progress towards UHC and to set specific targets for those hardest to reach with essential health services, such as children and adolescents. We also call for a commitment for user fees to be avoided for essential services in countries where they can be prohibitively expensive. The prioritization of Primary Health Care is needed to achieve UHC and PHC must go beyond the facility level to the community and frontline health workforce teams. UHC plans should be developed to include capacity-building at the national level to promote a health workforce that can deliver essential health services for all ages. Special focus should be given to equipping community health workers with the appropriate training, tools, technology, salary and support to deliver UHC where people live. The achievement of the right to health through UHC is not solely the responsibility of Member States and requires the collective commitment and action of global duty bearers via international assistance and cooperation. We urge the establishment of a global pooled mechanism to fund the significant gap that exists between the horizon of what local governments can reasonably fund, and what is required for the achievement of UHC in LMICs.

The following statement—from Global Health Council (GHC) supported by the Global Health Technologies Coalition (GHTC), the Infectious Diseases Society of America (IDSA), and Management Sciences for Health (MSH)—was delivered at the 72nd World Health Assembly on agenda item 11.2: Public health emergencies: preparedness and response.GHC supported by GHTC, IDSA and MSH, applaud efforts to strengthen capacities to prepare for and respond to health emergencies. As organizations working on the front lines of infectious disease responses and R&D, we urge states to continue building capacities to detect, prevent and respond to health threats.We are concerned that emergency preparedness and response capacities in most countries remain inadequate. It takes only 36 hours for a dangerous pathogen to travel from a rural village to any major city in the world. Investments in preparedness including financing to stop outbreaks at their source should be a priority. States must prioritize development of vaccines, therapeutics, rapid diagnostics, medical countermeasures and other lifesaving tools to prevent the next outbreak from growing into a pandemic.The DRC Ebola outbreak highlights the urgent need to strengthen response capacities in conflict-affected and fragile settings. More investments in health systems strengthening, greater community engagement and culturally appropriate interventions are needed immediately, along with continued collaboration for supporting the advancement of Ebola vaccine candidates and mobilizing additional tools, such as mobile labs for rapid sampling.We encourage WHO to highlight the success of efforts to harmonize regulatory systems across regional economic communities globally and call on all stakeholders to strengthen global regulatory capacity. We request WHO to consider platform diagnostics for emerging infectious diseases as the SAGE works to expand the Essential Diagnostics List. We urge WHO to include efforts to prevent AMR in emergency preparedness and IHR-strengthening activities. Resource-limited countries bear a disproportionate burden of deaths from resistant infections. WHO must help countries strengthen antibiotic stewardship capacities while working to improve preparedness and response.